Sponsors

Atrandi Biosciences (FG Track Sponsor)

Atrandi Biosciences, founded in 2016, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preserving single-cell resolution. SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Headquartered in Vilnius, Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries.

Aldevron

Aldevron is a premier manufacturing partner, producing high-quality plasmid DNA, RNA, proteins, and other key components for the development of vaccines, gene and cell therapies, immunotherapies, and other treatments. Headquartered in Fargo, North Dakota, and as a part of the Danaher Corporation (NYSE: DHR) family of global science and technology companies, Aldevron supports thousands of scientists who are developing revolutionary, lifesaving treatments for millions of people.

IDT

For more than 35 years, Integrated DNA Technologies, Inc. (IDT) has been empowering genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification, and quality control capabilities available. Since its founding in 1987, IDT has progressed from a leading oligo manufacturer to a genomics solutions provider supporting key application areas such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP* services, IDT manufactures products used by scientists researching many forms of cancer and most inherited and infectious diseases. As the company seeks to fulfil its mission of accelerating the pace of genomics, the important acquisition of Archer™ NGS Research Assays was completed in Dec. 2022. When combined with its existing solutions, the expanded portfolio helps realize the shared vision of enabling researchers to rapidly move from the lab to life-changing advances.

ChemoMetec

ChemoMetec is a leading manufacturer of high-precision cell counting and analysis equipment.

Our robust Xcytomatic® and NucleoCounter® instruments are the most precise automated cell counters on the market and enable the development of reproducible processes and cGMP manufacturing of biological products.

The stellar support we offer from our field application scientists and engineers help thousands of biopharma customers integrate commercial-ready cell counting processes across sites. No matter the sample, location or user, our technology ensures consistent performance.

Ampliqon

Ampliqon is a Danish manufacturer specializing in two core areas:

1. High-quality PCR enzymes for research, diagnostics, and education.

2. Custom-made laboratory reagents produced to match your exact formulation, packaging, and workflow needs — ideal for labs and companies looking to outsource production of specialized solutions for laboratory use.

Our PCR enzyme collection supports all standard DNA amplification setups used in modern laboratories. Our specialized knowledge in enzyme purification and DNA amplification ensures reliable, high-performance products. Ampliqon offers high quality, flexibility, and a global network of trusted distributors.

 For applications requiring extreme accuracy, the AQ97 High Fidelity DNA Polymerase offers over 60x the fidelity of Taq, rapid elongation (~10 s/kb), and robust amplification of long targets (tested up to 18 kb) or GC-rich targets. In the AQ97 HiFi Hot Start 2x Master Mix, the polymerase is combined with optimized buffer, dNTPs, and MgCl₂ for room-temperature setup, enhanced specificity, and convenient, streamlined workflows.

BioSpring GmbH

Unleash the full potential of your nucleic acid technology!

BioSpring is a leading CDMO specializing in the manufacturing and analysis of synthetic nucleic acids and mRNA for diagnostic and therapeutic applications. With 650 employees we support biotech and pharmaceutical companies across all stages of drug development with high-quality cGMP manufacturing and analytics. Our platform technologies enable rapid process adaptation, ensuring efficient, scalable production. Recognized for technological leadership in gene editing and beyond, we provide drug substances for innovative nucleic acid-based therapies, including several approved drugs.

Lonza Bioscience Solutions

Lonza Bioscience Solutions provides life science researchers in academic and government institutions as well as major biotech and pharmaceutical organizations worldwide with the tools they need to develop and test critical disease-treating drugs and therapies, from basic research to final product release, including cell culture and discovery technologies, quality control tests and software for biomanufacturing.

Mission Bio

Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping researchers with the tools they need to better measure, characterize, and predict our resistance and response to new therapies. Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health. The company’s Tapestri Platform is being utilized by customers at leading research centers, pharmaceutical, and diagnostics companies worldwide. A Tapestri assay recently entered GMP qualification and validation, indicating that single-cell analysis is on its way to routine use in clinical trials to support the next wave of life-saving CGT treatments.

Synthego

Synthego is your CRISPR Guide, providing unparalleled access to CRISPR solutions at scale for applications from Discovery to Clinic. We strive to accelerate the therapeutic development process with best-in-class CRISPR solutions, simplified licensing, & expert guidance, driving the adoption and success of CRISPR-based therapies to benefit all patients.